Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial

BACKGROUND: The glucagon‐like peptide‐1 (GLP‐1) receptor agonist liraglutide may be beneficial in the regression of diabetic cardiomyopathy. South Asian ethnic groups in particular are at risk of developing type 2 diabetes. PURPOSE: To assess the effects of liraglutide on left ventricular (LV) diast...

Descripción completa

Detalles Bibliográficos
Autores principales: Paiman, Elisabeth H.M., van Eyk, Huub J., van Aalst, Minke M.A., Bizino, Maurice B., van der Geest, Rob J., Westenberg, Jos J.M., Geelhoed‐Duijvestijn, Petronella H., Kharagjitsingh, Aan V., Rensen, Patrick C.N., Smit, Johannes W.A., Jazet, Ingrid M., Lamb, Hildo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318583/
https://www.ncbi.nlm.nih.gov/pubmed/31799782
http://dx.doi.org/10.1002/jmri.27009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318583/
https://www.ncbi.nlm.nih.gov/pubmed/31799782
http://dx.doi.org/10.1002/jmri.27009

Ejemplares similares